Impact of Alcohol Intake on Parkinson’s Disease Risk and Progression: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies
The association between alcohol consumption and Parkinson’s disease (PD) risk remains unclear, whereas smoking has an inverse relationship with the disease. This study systematically reviewed and meta-analyzed 16 studies (2014-2024) from PubMed, Scopus, Web of Science, MEDLINE, and the CochraneCochrane is a global independent network of health practitioners researchers patient advocates and o... Library to assess the relationship between alcohol intake and PD risk, examining sex differences, dose-response patterns, smoking interactions, and genetic factors. Alcohol consumption was classified as low, moderate, or heavy, considering beverage type, sex, smoking status, and gene-environment interactions. Random-effects meta-analyses were used to evaluate sex-stratified and subtype-specific associations. PD progression, Mendelian randomization (MR), and gene-environment results were narratively synthesized. Sex-stratified analyses showed inverse associations between alcohol consumption and PD risk versus non-drinkers (lifetime relative risk [LRR] = -0.35 to -0.62), with significant effects in women and no association in low-level drinkers. Subtype analyses indicated protective effects for liquor (RR = -0.12) and wine (RR = -0.16), but not for low-level drinkers. Combined alcohol and smoking exposure produced the greatest PD risk reduction (LRR = -0.37), with pooled estimates confirming an inverse association (LRR = -0.20, I(2) = 90.1%). However, MR and gene-environment studies showed inconsistent evidence. Light-to-moderate alcohol consumption, particularly wine and liquor, may reduce PD risk, with the strongest effects when combined with smoking. These findings highlight the combined effects of sex, genetic susceptibility, and lifestyle factors. Further longitudinal and MR studies stratified by sex and genotype are needed to elucidate the mechanisms; however, smoking cannot be recommended due to its detrimental effects. (c) 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Additional Info
-
Authors
Hemeda S.; Elmadani M.; Merzah M.; Odeh A.; Pinter E.; Balas I.; Janszky J.; Pinter D.; Kovacs N. -
Issue
Periodical: Mov Disord - Edition: 20260124 -
Published Date
24 january 2026
Related items
- Exploring the Associations Between Mediterranean Diet Adherence and Autoinflammation-Associated Skin Diseases
- Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groups
- The illusion of healthy drinking: Methodological bias and selective reporting of effects shape evidence on alcohol and cardiovascular health
- A review of the relationship between dimensions of alcohol consumption and the burden of disease: 2026 update including Mendelian randomisation studies
- Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial